Intravenous Vitamin C for Severe COVID-19
Patients hospitalized with COVID-19 at 130 sites on 4 continents received little benefit from intravenous vitamin C, researchers report. The authors concluded that the intervention
Patients hospitalized with COVID-19 at 130 sites on 4 continents received little benefit from intravenous vitamin C, researchers report. The authors concluded that the intervention
Among people with chronic kidney disease (CKD), vitamin D therapy does not lower all-cause mortality in comparison with placebo, according to a systematic review and
In an important reaffirmation of prior guidance, the U.S. Preventive Services Task Force (USPSTF) “recommends that all persons planning to or who could become pregnant
The risk of progressing to type 2 diabetes is reduced by vitamin D therapy in people with prediabetes, according to a systematic review and meta-analysis.
In Diabetes Care, 2 studies report associations of sodium–glucose cotransporter 2 inhibitor (SGLT2i) use with lower risks of atrial fibrillation (AF) and dementia. A third
Higher levels of omega-3 polyunsaturated fatty acids (n-3 PUFA) from seafood are associated with protection from incident chronic kidney disease (CKD), according to a pooled
IV ferric derisomaltose was associated with a lower risk of hospital admissions for heart failure and cardiovascular death in a broad range of patients with
In a study of ambulatory and hospitalized patients with COVID-19, oral zinc for 15 days decreased the 30-day death rate, lowered the intensive care unit
In a White European population, all-cause mortality decreased on a steep, nonlinear, L-shaped curve with increasing levels of 25-hydroxyvitamin D (25-(OH)D) up to 50 nmol/L,